UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053811
Receipt number R000061404
Scientific Title Efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency of the gasserian ganglion in patients with trigeminal neuralgia.
Date of disclosure of the study information 2024/03/20
Last modified on 2024/04/14 12:50:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency of the gasserian ganglion in patients with trigeminal neuralgia.

Acronym

Efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency in the treatment of trigeminal neuralgia.

Scientific Title

Efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency of the gasserian ganglion in patients with trigeminal neuralgia.

Scientific Title:Acronym

Efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency in the treatment of trigeminal neuralgia.

Region

Japan


Condition

Condition

Trigeminal Neuralgia

Classification by specialty

Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and complications of combined pulsed radiofrequency and low-temperature thermal radiofrequency of the gasserian ganglion in patients with trigeminal neuralgia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Numerical Rating Scale

Key secondary outcomes

Barrow Neurological Institute Pain Intensity Score (BNI-P)
Barrow Neurological Institute Facial Numbness Score (BNI-N)
Likert score
Numbness level from 0 to 10


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

# Trigeminal neuralgia patients approved by ethics committee
# NRS>=5
# BNI-P score:3b-5
# BNI-N score:3-4
# Trigeminal neuralgia patients met the diagnostic criteria for gasserian ganglion blockage
# Written concent to participate in this study
# Age>=18years

Key exclusion criteria

# Pregnant women
# Allagy to contrast agent and propofol
# Seriou systemic diseases that can influence the assessment of this study
# Judged as unmet by reserchers

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kenya
Middle name
Last name Kamijima

Organization

NTT Medical Center Tokyo

Division name

Pain clinic

Zip code

141-8625

Address

5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo

TEL

0334486031

Email

painnttk@yahoo.co.jp


Public contact

Name of contact person

1st name Shintaro
Middle name
Last name Hagihara

Organization

Kagoshima University

Division name

Anesthesiology

Zip code

890-8520

Address

8-35-1 Sakuragaoka, Kagoshima, Japan

TEL

0992755430

Homepage URL


Email

hagihasg2@gmail.com


Sponsor or person

Institute

NTT Medical Center Tokyo

Institute

Department

Personal name

Kenya Kamijima


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Anesthesiology, Kagoshima University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagoshima Univerity

Address

8-35-1 Sakuragaoka, Kagoshima, Japan.

Tel

0992755430

Email

hagihasg2@gmail.com


Secondary IDs

Secondary IDs

YES

Study ID_1

000200011361-01

Org. issuing International ID_1

NTT Medical Center Tokyo

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

NTT東日本関東病院(東京都)、鹿児島大学病院(鹿児島)


Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 03 Month 20 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Currently in the process of applying.


Management information

Registered date

2024 Year 03 Month 09 Day

Last modified on

2024 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061404


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name